Neuroone Medical Technologies (NMTC) Invested Capital (2016 - 2025)
Historic Invested Capital for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to $6.4 million.
- Neuroone Medical Technologies' Invested Capital rose 11810.18% to $6.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.4 million, marking a year-over-year increase of 11810.18%. This contributed to the annual value of $7.1 million for FY2025, which is 76039.05% up from last year.
- As of Q4 2025, Neuroone Medical Technologies' Invested Capital stood at $6.4 million, which was up 11810.18% from $7.1 million recorded in Q3 2025.
- Over the past 5 years, Neuroone Medical Technologies' Invested Capital peaked at $15.9 million during Q4 2021, and registered a low of $822013.0 during Q3 2024.
- Moreover, its 5-year median value for Invested Capital was $6.5 million (2021), whereas its average is $6.9 million.
- Per our database at Business Quant, Neuroone Medical Technologies' Invested Capital surged by 103253.32% in 2021 and then crashed by 8711.28% in 2024.
- Quarter analysis of 5 years shows Neuroone Medical Technologies' Invested Capital stood at $15.9 million in 2021, then plummeted by 48.76% to $8.2 million in 2022, then crashed by 45.93% to $4.4 million in 2023, then crashed by 33.56% to $2.9 million in 2024, then surged by 118.1% to $6.4 million in 2025.
- Its Invested Capital was $6.4 million in Q4 2025, compared to $7.1 million in Q3 2025 and $8.2 million in Q2 2025.